Martha Goldberg Aronson - 05 Aug 2022 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 05 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Aug 2022, 16:18:01 UTC
Previous filing: 02 Jun 2022
Next filing: 17 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CSII	Common Stock						10,000	05 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Award	$0	+9,064		$0.000000	9,064	05 Aug 2022	Common Stock	9,064		Direct	F3
holding	CSII	Restricted Stock Units						20,752	05 Aug 2022	Common Stock	20,752		Direct	F1
holding	CSII	Restricted Stock Units						2,411	05 Aug 2022	Common Stock	2,411		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 2,266 shares on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.